MedPath

厦门紫旭医药科技有限公司

Ownership
-
Established
2009-08-05
Employees
-
Market Cap
-
Website
www.zixuyy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Oxytocin Injection

Product Name
缩宫素注射液
Approval Number
国药准字H20233068
Approval Date
Jan 19, 2023
NMPA

Levocetirizine Dihydrochloride Oral Drops

Product Name
盐酸左西替利嗪口服滴剂
Approval Number
国药准字H20213695
Approval Date
Sep 1, 2021
NMPA

Levocetirizine Dihydrochloride Oral Drops

Product Name
盐酸左西替利嗪口服滴剂
Approval Number
国药准字H20213694
Approval Date
Sep 1, 2021
NMPA

Levocetirizine Dihydrochloride Oral Solution

Product Name
盐酸左西替利嗪口服溶液
Approval Number
国药准字H20213134
Approval Date
Feb 24, 2021
NMPA

Levocetirizine Dihydrochloride Oral Solution

Product Name
盐酸左西替利嗪口服溶液
Approval Number
国药准字H20213133
Approval Date
Feb 24, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.